This section gives details of Final Determinations made in accordance with Regulation 3(1) of the Medicines for Human Use (Marketing Authorisations etc.) Regulations 1994 or Regulation 3a of the Medicines for Human Use (Marketing Authorisations etc.) Regulations 1994 as amended.
Final Determinations are issued by the Borderline Section of the MHRA on behalf of the Licensing Authority of the United Kingdom. It should be noted that determinations are made on the basis of the product status at the time it was investigated. Many products will continue to be marketed in the UK having made appropriate modifications to ingredients and/or product presentation, to bring them into line with the Regulations.
For further information on Final Determinations, please contact our Borderline Section, 151 Buckingham Palace Road, London SW1W 9SZ, telephone 020 3080 6759 or email info@mhra.gsi.gov.uk.
